Expression analysis of MIR182 and its associated target genes in advanced ovarian carcinoma
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Expression analysis of MIR182 and its associated target genes in advanced ovarian carcinoma
Authors
Keywords
-
Journal
MODERN PATHOLOGY
Volume 25, Issue 12, Pages 1644-1653
Publisher
Springer Nature
Online
2012-07-13
DOI
10.1038/modpathol.2012.118
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Breast cancer 1 (BRCA1) protein expression as a prognostic marker in sporadic epithelial ovarian carcinoma: an NCIC CTG OV.16 correlative study
- (2011) J. I. Weberpals et al. ANNALS OF ONCOLOGY
- HMGA2Overexpression-Induced Ovarian Surface Epithelial Transformation Is Mediated Through Regulation of EMT Genes
- (2011) Jingjing Wu et al. CANCER RESEARCH
- BRCA1 is both a prognostic and predictive biomarker of response to chemotherapy in sporadic epithelial ovarian cancer
- (2011) Judith E. Carser et al. GYNECOLOGIC ONCOLOGY
- Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer
- (2011) Shiyu Zhang et al. GYNECOLOGIC ONCOLOGY
- Loss of BRCA1 Protein Expression as Indicator of the BRCAness Phenotype Is Associated With Favorable Overall Survival After Complete Resection of Sporadic Ovarian Cancer
- (2011) Marc P. Radosa et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory
- (2010) Robert J. Kurman et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- miRNA profiling along tumour progression in ovarian carcinoma
- (2010) Olga Vaksman et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- HMGA2: A biomarker significantly overexpressed in high-grade ovarian serous carcinoma
- (2010) Aparna Mahajan et al. MODERN PATHOLOGY
- miR-182-Mediated Downregulation of BRCA1 Impacts DNA Repair and Sensitivity to PARP Inhibitors
- (2010) Patryk Moskwa et al. MOLECULAR CELL
- HMGA2: A Potential Biomarker Complement to P53 for Detection of Early-stage High-grade Papillary Serous Carcinoma in Fallopian Tubes
- (2009) Jian-Jun Wei et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Low expression of Foxo3a is Associated with Poor Prognosis in Ovarian Cancer Patients
- (2009) Min Fei et al. CANCER INVESTIGATION
- Definition of microRNAs That Repress Expression of the Tumor Suppressor Gene FOXO1 in Endometrial Cancer
- (2009) S. S. Myatt et al. CANCER RESEARCH
- Metastasis suppressor 1 (MTSS1) demonstrates prognostic value and anti-metastatic properties in breast cancer
- (2009) Christian Parr et al. EUROPEAN JOURNAL OF CANCER
- Derepression of HMGA2 via Removal of ZBRK1/BRCA1/CtIP Complex Enhances Mammary Tumorigenesis
- (2009) Kazi Mokim Ahmed et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Coordinate Regulation of FOXO1 by miR-27a, miR-96, and miR-182 in Breast Cancer Cells
- (2009) Irene K. Guttilla et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor
- (2009) Miguel F. Segura et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities
- (2008) Joshua Z Press et al. BMC CANCER
- Forkhead box-O transcription factor: critical conductors of cancer's fate
- (2008) C. Weidinger et al. ENDOCRINE-RELATED CANCER
- New Insights Into the Pathogenesis of Serous Ovarian Cancer and Its Clinical Impact
- (2008) Keren Levanon et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation